Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

You are here: Home / Statistics / Comparative statistics by cancer site (ICD-10)

You are here: Home / Statistics / Comparative statistics by cancer site (ICD-10)

Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site

Click on country-registry for comparison

Flag	Country Registry	Registration period	No. of cases included	Complete FU		Incomplete FU: loss to FU						% with Complete FU at 5 years	Median FU (in months)
				Alive/dead	At end of FU	No.	%	% lost to FU: years from diagnosis
				No.	%	No.	%	<1	1-3	3-5	>5
	China - Shangai	1992-1995	548	541	98.7	7	1.3	0.2	0.3	0.4	0.4	99.1	62.1
	Costa Rica	1995-2000	1485	1001	67.4	484	32.6	9.9	8.6	7.8	6.3	73.7	30.9
	Cuba	1994-1995	1221	1152	94.4	69	5.6	2.2	1.2	1.7	0.5	94.9	50.4
	Gambia	1993-1997	202	193	95.5	9	4.5	4.5	0.0	0.0	0.0	95.5	5.6
	India - Barshi	1993-2000	406	403	99.3	3	0.7	0.2	0.0	0.2	0.2	99.5	24.4
	India - Chennai	1990-1999	4438	2752	62.0	1686	38.0	11.0	3.7	2.5	20.8	82.8	27.5
	India - Karunagappally	1991-1997	170	169	99.4	1	0.6	0.0	0.6	0.0	0.0	99.4	38.5
	India - Mumbai	1992-1994	4436	3290	74.2	1146	25.8	14.1	0.2	0.3	11.2	85.3	25.1
	Philippines - Manila	1994-1995	377	288	76.4	89	23.6	13.8	4.5	1.9	3.4	79.8	14.6
	Thailand - Chiang Mai	1993-1997	885	621	70.2	264	29.8	6.7	8.4	10.1	4.8	75.0	38.0
	Thailand - Khon Kaen	1993-1997	554	210	37.9	344	62.1	39.2	15.9	5.1	1.9	39.8	9.9
	Thailand - Lampang	1990-2000	1079	1064	98.6	15	1.4	0.0	0.0	0.6	0.7	99.4	63.6
	Thailand - Songkhla	1990-1999	780	422	54.1	358	45.9	13.2	12.1	8.6	12.1	66.2	33.5
	Turkey - Izmir	1995-1997	246	127	51.6	119	48.4	10.6	3.7	2.4	31.7	83.3	51.9
	Uganda - Kampala	1993-1997	283	149	52.7	134	47.3	35.0	11.3	0.7	0.4	53.0	8.3
	Zimbabwe - Harare	1993-1997	264	260	98.5	4	1.5	1.1	0.4	0.0	0.0	98.5	26.2

Other tables available:

- Table 1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a:	Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b:	Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b:	Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6:	Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9:	Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period